EUVIMEDEUVIMED entdecken
Querschnittstudie

Telomere length in leukocyte as biomarker for diagnosis of primary Sjögren’s syndrome: a cross-sectional study

Fang Han, Ronglin Gao, Haohui Fan, Jincheng Pu, Lufei Yang, Yanqing Wang, Jiamin Song, Chunrui Li, Yuqi Wang, Jianping Tang, Xuan Wang

Clinical Rheumatology · 2026

DOI: 10.1007/s10067-025-07804-2 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Fang Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, School of Medicine, Tongji Hospital, Tongji University, No. 389 Xincun Road, Shanghai, 200065, China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Leukocytes, Telomere. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Primary Sjögren's syndrome (pSS), a systemic autoimmune disorder, is recognized by immune dysregulation and chronic inflammation. Though telomere attrition has been linked to various immune-related diseases, its relationship with pSS pathogenesis remains poorly understood. This research seeks to explore the relationship between peripheral blood leukocytes' telomere length and the susceptibility to pSS, thereby offering insights into the potential role as a biomarker. METHODS: 181 participants, comprising pSS patients (n = 87) and healthy controls (n = 94) were involved in this study. Relative length of leukocyte telomere (T/S ratio) was quantified by a validated quantitative PCR protocol. To define the independent effect of telomere length on pSS susceptibility, logistic regression analyses, including univariate and multivariable, were performed. In addition, generalized additive modeling (GAM) was applied to identify possible nonlinear dose-response patterns. RESULTS: pSS patients demonstrated significantly shorter telomere lengths than healthy controls (mean T/S ratio: 0.8 ± 0.35 vs. 1.01 ± 0.49, P = 0.0019). Decreased length of telomere was strongly linked to a higher likelihood of pSS occurrence (OR = 0.31, 95% CI: 0.15-0.66, P = 0.0021). This relationship stayed statistically meaningful, albeit slightly weakened, after accounting for clinical characteristics and therapeutic variables. Moreover, nonlinear modeling suggested that progressive telomere shortening corresponded to a rising probability of developing pSS, implying a potential mechanistic contribution of telomere erosion to disease development. CONCLUSION: This cross-sectional study indicates that reduced telomere length in peripheral blood leukocytes is linked to an elevated likelihood of developing pSS, suggesting that telomere dynamics could function as a promising biomarker for early detection and risk assessment. Future longitudinal studies are warranted to confirm causality and assess telomere-targeted interventions. Key Points • Leukocyte telomere shortening serves as a clinically relevant biomarker in pSS. • Nonlinear dynamics link telomere attrition to immune dysregulation. • Telomere length shows complex interaction with disease stage and therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeLeukocytesTelomereHumansCross-Sectional StudiesFemaleMiddle AgedMaleBiomarkersAdultAgedCase-Control StudiesTelomere Shortening

Stichwörter der Autor:innen

Autoimmune diseaseLeukocyte telomere attritionPrimary Sjögren’s syndromeTelomere length

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, School of Medicine, Tongji Hospital, Tongji University, No. 389 Xincun Road, Shanghai, 200065, China.
  • Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Rheumatology and Immunology, School of Medicine, Tongji Hospital, Tongji University, No. 389 Xincun Road, Shanghai, 200065, China. xuan2018@tongji.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai Municipality
  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Sailing Program
  • Shanghai Wu Mengchao Medical Foundation
  • Sixth cycle of key cultivation disciplines of Tongji Hospital Tongji University
  • Clinical research program of Tongji Hospital Tongji University
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Han, F., Gao, R., Fan, H., Pu, J., Yang, L., Wang, Y., Song, J., Li, C., Wang, Y., Tang, J., & Wang, X. (2026). Telomere length in leukocyte as biomarker for diagnosis of primary Sjögren’s syndrome: a cross-sectional study. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07804-2

Vancouver

Han F, Gao R, Fan H, Pu J, Yang L, Wang Y, et al. Telomere length in leukocyte as biomarker for diagnosis of primary Sjögren’s syndrome: a cross-sectional study. Clinical Rheumatology. 2026. doi:10.1007/s10067-025-07804-2

BibTeX
@article{Han2026,
  author = {Han, Fang and Gao, Ronglin and Fan, Haohui and Pu, Jincheng and Yang, Lufei and Wang, Yanqing and Song, Jiamin and Li, Chunrui and Wang, Yuqi and Tang, Jianping and Wang, Xuan},
  title = {Telomere length in leukocyte as biomarker for diagnosis of primary Sjögren’s syndrome: a cross-sectional study},
  journal = {Clinical Rheumatology},
  year = {2026},
  doi = {10.1007/s10067-025-07804-2}
}
Kostenlos starten →